Abstract
BACKGROUND: – Drug-coated balloons (DCBs) are now a Food and Drug Administration-approved treatment option for the management of in-stent restenosis (ISR) based on superior outcomes compared with plain old balloon angioplasty (POBA) alone. However, the efficacy of DCB compared with drug-eluting stent (DES; repeat stenting) for ISR is uncertain, with prior studies showing inferiority of DCB. We aimed to compare the outcomes of DES, DCB, or POBA in patients with coronary ISR. METHODS: – We searched PubMed, EMBASE, and https://www.crd.york.ac.uk/PROSPERO; Unique identifier: CRD42024598433.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e015161 |
| Journal | Circulation: Cardiovascular Interventions |
| Volume | 18 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2025 |
Keywords
- coronary artery disease
- drug-eluting stents
- percutaneous coronary intervention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Drug-Eluting Stent, Drug-Coated Balloon, or Plain Old Balloon Angioplasty for In-Stent Coronary Restenosis: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS